Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Enzymes”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Not applicableStudy completedNCT00037076
What this trial is testing

Prevalence of Hepatitis C Virus Infection in HIV-Infected Children

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 600
Not applicableStudy completedNCT06697977
What this trial is testing

Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDInsulin ResistanceMetabolic Syndrome+4 more
University of Jordan 27
Not applicableStudy completedNCT01707914
What this trial is testing

Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subjects With Features of Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Shaoguan University 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT06239155
What this trial is testing

A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Ascentawits Pharmaceuticals, Ltd 51
Large-scale testing (Phase 3)Ended earlyNCT01009593
What this trial is testing

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma RecurrentCarcinoma, Hepatocellular+10 more
Abbott 1,035
Testing effectiveness (Phase 2)Ended earlyNCT01226797
What this trial is testing

Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes

Who this might be right for
Hepatitis C, Chronic
Pfizer 24
Not applicableNot Yet RecruitingNCT07236697
What this trial is testing

Impact of Subclinical Hypothyroidism on Liver Enzymes and Lipid Profile

Who this might be right for
Subclinical Hypothyroidism
Assiut University 120
Large-scale testing (Phase 3)UnknownNCT03216668
What this trial is testing

TONKA Versus Legalon for Lowering Hepatic Enzymes in Liver Function Disorder Patients.

Who this might be right for
Liver Function Failure
Nhat Nhat Pharmaceutical Company 140
Large-scale testing (Phase 3)Study completedNCT02030977
What this trial is testing

The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Fatty Liver
Dr Azita Hekmatdoost 50
Early research (Phase 1)Study completedNCT04723602
What this trial is testing

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
Albert B. Sabin Vaccine Institute 32
Early research (Phase 1)WithdrawnNCT07123363
What this trial is testing

Effect of Bitopertin on the Liver and on Levels of Protoporphyrin IX in Bile, Blood, Liver, and Stool in Patients With Erythropoietic Protoporphyria/X-linked Protoporphyria and Increased Liver Stiffness and/or Liver Enzymes at Baseline

Who this might be right for
Protoporphyria
Wake Forest University Health Sciences
Post-approval studies (Phase 4)Study completedNCT03121521
What this trial is testing

The Effects of Melatonin on Elevated Liver Enzymes During Statins Treatment

Who this might be right for
Hepatopathy
Medical University of Lodz 60
Testing effectiveness (Phase 2)Study completedNCT01307098
What this trial is testing

Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency

Who this might be right for
Cholesterol Ester Storage Disease(CESD)Lysosomal Acid Lipase DeficiencyLAL-Deficiency
Alexion Pharmaceuticals, Inc. 9
Not applicableStudy completedNCT00326482
What this trial is testing

Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy

Who this might be right for
Liver FibrosisSteatohepatitisElevated Transaminases
National Institute of Allergy and Infectious Diseases (NIAID) 127
Early research (Phase 1)Study completedNCT02138799
What this trial is testing

Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men

Who this might be right for
Drug-Drug Interaction (DDI)Healthy SubjectsPharmacokinetics of Enzalutamide
Astellas Pharma Europe B.V. 28
Not applicableNo Longer AvailableNCT00962260
What this trial is testing

Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease

Who this might be right for
Gaucher Disease
Pfizer
Large-scale testing (Phase 3)Study completedNCT05144217
What this trial is testing

Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo

Who this might be right for
Drug-induced Liver Injury
Prof. Dr. Frank Behrens 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07025980
What this trial is testing

Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Diabetes MellitusHypertension+1 more
Eva Cubric
Testing effectiveness (Phase 2)Study completedNCT04722887
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

Who this might be right for
Alpha1-Antitrypsin Deficiency
Grifols Therapeutics LLC 17
Not applicableStudy completedNCT06067711
What this trial is testing

Response of Liver to 12 Weeks of Resistance Band Training Program in Burned Patients.

Who this might be right for
Burns
Cairo University 60
Next Page
114